Genesis Prize 2022

Albert Bourla, chairman and CEO of Pfizer, has been awarded the 2022 Genesis Prize for his “leadership, determination and especially for his willingness to assume great risks” in developing a coronavirus vaccine in record time.
Pfizer's vaccine was the first to win U.S. approval for emergency use in December 2020.
The Genesis Prize is a $1 million annual prize awarded to Jewish people who have achieved significant professional success, in recognition of their accomplishments, contributions to humanity, and commitment to Jewish values.
The prize was inaugurated in 2014 and is run in a partnership between the private Genesis Prize Foundation and the chairman’s office of the Jewish Agency, a nonprofit group that has close ties to the Israeli government.
The prize is usually awarded in Jerusalem each June at a dinner attended by Israel’s prime minister. But the ceremony has been called off the past two years due to the pandemic.